InvestorsHub Logo

Gonzal

08/08/23 5:46 PM

#42446 RE: iRobot #42445

Not accurate statement you made.

This analysis does not address the association of metformin with incidence or progression of AMD.

From my understanding CUBT is not in the prevention business nor cure business… they are in the “Disease-Modifying” business.

They will imo study the Disease Modifying outcomes of ophthalmic drops on active AMD patients.